Cellares, the automated cell therapy manufacturer that has risen rapidly since its 2019 founding in South San Francisco, is now confronting a significant business setback. Co-founder and CEO Fabian Gerlinghaus revealed over
MoreEli Lilly (LLY) has released a new campaign spotlighting the decades-long struggles of older obesity patients and its Medicare GLP-1 Bridge program. The campaign, titled “A Life Covered,” is the latest short
MoreRFK Jr. Seeks Public Input On Childhood Vaccine Classification Framework After Trump Executive Order
Health and Human Services Secretary Robert F. Kennedy Jr. is pushing to overhaul how the United States develops and categorises its childhood vaccine recommendations. Kennedy posted a Request for Information on Friday,
MoreSwedish drugmaker Hansa Biopharma is positioning itself for a potential US stock market listing as a critical regulatory verdict on its kidney transplant drug draws near. The company submitted draft forms to
MoreMerck and AstraZeneca have suffered fresh legal defeats in their efforts to block the government’s Medicare drug price negotiation programme under the Inflation Reduction Act. The U.S. Court of Appeals for the
MoreIndependent pharmacies across the United States are under mounting financial strain, with a significant portion of owners now weighing whether to shut their businesses entirely. A recent National Community Pharmacists Association survey
MoreDaiichi Sankyo is promoting Ken Keller to lead a newly created globally integrated commercialization unit as part of its ambition to become a top five oncology company by 2035. The Japanese drugmaker
MoreA new survey from the Academy of Managed Care Pharmacy reveals persistent doubt among health plans and pharmacy benefit managers about the TrumpRx platform’s real-world savings. The TrumpRx platform has been live
MoreCommunity Health Media (CHM) is positioning community physicians and key opinion leaders as the central figures in a new model of medical content creation and distribution. The company, known as a medical
MoreGenetix Biotherapeutics Inc. and the National Football League Alumni Association have launched a national awareness and education initiative focused on sickle cell disease. The partnership aims to raise greater public understanding of
More
